Cargando…
QHRD106 ameliorates ischemic stroke injury as a long-acting tissue kallikrein preparation
Ischemic stroke is the second leading cause of death worldwide, and there are limited effective treatment strategies. QHRD106, a polyethyleneglycol (PEG)-modified long-acting tissue kallikrein preparation, has not been reported previously. In this study, we aimed to investigate the therapeutic effec...
Autores principales: | Xu, Si-Yi, Jia, Jun-Qiu, Sun, Min, Bao, Xin-Yu, Xia, Sheng-Nan, Shu, Shu, Liu, Pin-yi, Ji, Sen-lin, Ye, Lei, Cao, Xiang, Xu, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366503/ https://www.ncbi.nlm.nih.gov/pubmed/37496671 http://dx.doi.org/10.1016/j.isci.2023.107268 |
Ejemplares similares
-
Human tissue kallikrein in the treatment of acute ischemic stroke
por: Alexander-Curtis, Michelle, et al.
Publicado: (2019) -
Poncirin suppresses lipopolysaccharide (LPS)-induced microglial inflammation and ameliorates brain ischemic injury in experimental stroke in mice
por: Yang, Li-Xuan, et al.
Publicado: (2020) -
High Level of Serum Tissue Kallikrein Is Associated with Favorable Outcome in Acute Ischemic Stroke Patients
por: Wu, Fei, et al.
Publicado: (2019) -
AIM2 deletion enhances blood‐brain barrier integrity in experimental ischemic stroke
por: Xu, Si‐yi, et al.
Publicado: (2021) -
TMEM16A Inhibition Preserves Blood–Brain Barrier Integrity After Ischemic Stroke
por: Liu, Pin-yi, et al.
Publicado: (2019)